Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan
β Scribed by Sasaki, H; Manabe, A; Kojima, S; Tsuchida, M; Hayashi, Y; Ikuta, K; Okamura, J; Koike, K; Ohara, A; Ishii, E
- Book ID
- 110055029
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 173 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Although unexplained anemia is common in the elderly, the prevalence of MDS is poorly defined. We reviewed 2267 bone marrows reviewed at our center between the years 2002 and 2005. Of these, 322 met our criteria for inclusion (14%). Seventy-three patients (22.6%) had a confirmed diagnosis of MDS and
## Abstract ## BACKGROUND: Azacitidine induces responses and prolongs overall survival compared with conventional care regimens in patients who have highβrisk myelodysplastic syndromes (MDS). However, limited data are available concerning the efficacy and safety of azacitidine in patients who have